ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,030 | -70.1% | 85 | -61.4% | 0.00% | -100.0% |
Q2 2023 | $10,149 | +31.8% | 220 | +14.6% | 0.00% | 0.0% |
Q1 2023 | $7,699 | -62.2% | 192 | -56.4% | 0.00% | -66.7% |
Q4 2022 | $20,385 | +307.7% | 440 | +286.0% | 0.00% | +200.0% |
Q3 2022 | $5,000 | +150.0% | 114 | +307.1% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 28 | +16.7% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 24 | +242.9% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 7 | -58.8% | 0.00% | – |
Q4 2019 | $1,000 | -75.0% | 17 | -80.5% | 0.00% | -100.0% |
Q3 2019 | $4,000 | 0.0% | 87 | +38.1% | 0.00% | 0.0% |
Q2 2019 | $4,000 | 0.0% | 63 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $4,000 | +100.0% | 63 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $2,000 | – | 63 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |